{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-007376","form_type":"8-K","ticker":"TNYA","cik":"0001858848","company_name":"Tenaya Therapeutics, Inc.","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.211600+00:00","generated_at":"2026-06-18T04:55:09.561196+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Tenaya says SVB exposure minimal; loss immaterial","bullets":["Maintains operating accounts at SVB with minimal balance relative to total cash and investments.","Believes exposure to loss from SVB receivership is immaterial.","No specific dollar amount disclosed; total cash position not provided."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-007376","json":"https://secwatch.observer/filing/0000950170-23-007376.json","markdown":"https://secwatch.observer/filing/0000950170-23-007376.md","text":"https://secwatch.observer/filing/0000950170-23-007376.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858848/000095017023007376/0000950170-23-007376-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858848/000095017023007376/tnya-20230310.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:55:09.561196+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}